Skip to main content
Erschienen in:

21.09.2021 | Koronare Herzerkrankung | Curriculum Zur Zeit gratis

Manual der Arbeitsgruppe Interventionelle Kardiologie (AGIK) der Deutschen Gesellschaft für Kardiologie – Herz- und Kreislaufforschung e.V. (DGK)

Teil 2: „Durchführung der perkutanen Koronarintervention“

verfasst von: Prof. Dr. med. Holger M. Nef, Stephan Achenbach, Ralf Birkemeyer, Alexander Bufe, Oliver Dörr, Albrecht Elsässer, Luise Gaede, Tommaso Gori, Hans M. Hoffmeister, Felix J. Hofmann, Hugo A. Katus, Christoph Liebetrau, Steffen Massberg, Matthias Pauschinger, Thomas Schmitz, Tim Süselbeck, Wolfram Voelker, Jens Wiebe, Ralf Zahn, Christian Hamm, Andreas M. Zeiher, Helge Möllmann

Erschienen in: Die Kardiologie | Ausgabe 6/2021

Einloggen, um Zugang zu erhalten

Zusammenfassung

Dieses Manual zur interventionellen Therapie (Teil 2) ist eine Anwendungsempfehlung für interventionell tätige Ärzte, die den gegenwärtigen Kenntnisstand unter Berücksichtigung neuester Studienergebnisse wiedergibt. Hierzu wurde in den einzelnen Kapiteln speziell auf die Alltagstauglichkeit der Empfehlungen geachtet, sodass dieses Manual jedem interventionell tätigen Kardiologen als Entscheidungshilfe im Herzkatheterlabor dienen soll. Trotz der von vielen Experten eingebrachten praktischen Hinweise kann dieses Manual dennoch nicht die ärztliche Evaluation des individuellen Patienten ersetzen und damit eine Anpassung der Diagnostik bzw. Therapie ersetzen.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Deutsche Herzstiftung (2018) Deutscher Herzbericht Bd. 30 Deutsche Herzstiftung (2018) Deutscher Herzbericht Bd. 30
3.
Zurück zum Zitat Bonzel T et al (2008) Percutaneous coronary interventions (PCI). Clin Res Cardiol 97(8):513–547PubMed Bonzel T et al (2008) Percutaneous coronary interventions (PCI). Clin Res Cardiol 97(8):513–547PubMed
4.
Zurück zum Zitat Hamm CW et al (2008) Diagnostic heart catheterization. Clin Res Cardiol 97(8):475–512PubMed Hamm CW et al (2008) Diagnostic heart catheterization. Clin Res Cardiol 97(8):475–512PubMed
5.
Zurück zum Zitat Patil D et al (2017) Appropriateness of elective percutaneous coronary intervention and impact of government health insurance scheme—A tertiary centre experience from Western India. Indian Heart J 69(5):600–606PubMedPubMedCentral Patil D et al (2017) Appropriateness of elective percutaneous coronary intervention and impact of government health insurance scheme—A tertiary centre experience from Western India. Indian Heart J 69(5):600–606PubMedPubMedCentral
6.
Zurück zum Zitat Neumann FJ et al (2019) 2018 ESC/EACTS Guidelines on myocardial revascularization. Eur Heart J 40(2):87–165PubMed Neumann FJ et al (2019) 2018 ESC/EACTS Guidelines on myocardial revascularization. Eur Heart J 40(2):87–165PubMed
7.
Zurück zum Zitat Schachinger V et al (2015) Guidelines to establish and operate catheterization laboratories and hybrid operating rooms/hybrid laboratories (3rd edition 2015). Kardiologe 9(1):89–123 Schachinger V et al (2015) Guidelines to establish and operate catheterization laboratories and hybrid operating rooms/hybrid laboratories (3rd edition 2015). Kardiologe 9(1):89–123
8.
Zurück zum Zitat Bonzel T, Wollschlager H, Just H (1986) A new catheter system for the mechanical dilatation of coronary stenoses with exchangeable intracoronary catheters, fast flow of the contrast agent and improved control. Biomed Tech 31(9):195–200 Bonzel T, Wollschlager H, Just H (1986) A new catheter system for the mechanical dilatation of coronary stenoses with exchangeable intracoronary catheters, fast flow of the contrast agent and improved control. Biomed Tech 31(9):195–200
9.
Zurück zum Zitat Brophy JM, Belisle P, Joseph L (2003) Evidence for use of coronary stents. A hierarchical bayesian meta-analysis. Ann Intern Med 138(10):777–786PubMed Brophy JM, Belisle P, Joseph L (2003) Evidence for use of coronary stents. A hierarchical bayesian meta-analysis. Ann Intern Med 138(10):777–786PubMed
10.
Zurück zum Zitat Carrie D et al (2001) Comparison of direct coronary stenting with and without balloon predilatation in patients with stable angina pectoris. Am J Cardiol 87(6):693–698PubMed Carrie D et al (2001) Comparison of direct coronary stenting with and without balloon predilatation in patients with stable angina pectoris. Am J Cardiol 87(6):693–698PubMed
11.
Zurück zum Zitat Ijsselmuiden AJ et al (2003) Direct coronary stenting compared with stenting after predilatation is feasible, safe, and more cost-effective in selected patients: evidence to date indicating similar late outcomes. Int J Cardiovasc Intervent 5(3):143–150PubMed Ijsselmuiden AJ et al (2003) Direct coronary stenting compared with stenting after predilatation is feasible, safe, and more cost-effective in selected patients: evidence to date indicating similar late outcomes. Int J Cardiovasc Intervent 5(3):143–150PubMed
12.
Zurück zum Zitat Ijsselmuiden AJJ et al (2003) Direct coronary stent implantation does not reduce the incidence of in-stent restenosis or major adverse cardiac events: six month results of a randomized trial. Eur Heart J 24(5):421–429PubMed Ijsselmuiden AJJ et al (2003) Direct coronary stent implantation does not reduce the incidence of in-stent restenosis or major adverse cardiac events: six month results of a randomized trial. Eur Heart J 24(5):421–429PubMed
13.
Zurück zum Zitat Bondesson P et al (2012) Comparison of two drug-eluting balloons: a report from the SCAAR registry. EuroIntervention 8(4):444–449PubMed Bondesson P et al (2012) Comparison of two drug-eluting balloons: a report from the SCAAR registry. EuroIntervention 8(4):444–449PubMed
14.
Zurück zum Zitat Scheller B et al (2006) Treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter. N Engl J Med 355(20):2113–2124PubMed Scheller B et al (2006) Treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter. N Engl J Med 355(20):2113–2124PubMed
15.
Zurück zum Zitat Habara S et al (2011) Effectiveness of paclitaxel-eluting balloon catheter in patients with sirolimus-eluting stent restenosis. JACC Cardiovasc Interv 4(2):149–154PubMed Habara S et al (2011) Effectiveness of paclitaxel-eluting balloon catheter in patients with sirolimus-eluting stent restenosis. JACC Cardiovasc Interv 4(2):149–154PubMed
16.
Zurück zum Zitat Rittger H et al (2012) A randomized, multicenter, single-blinded trial comparing paclitaxel-coated balloon angioplasty with plain balloon angioplasty in drug-eluting stent restenosis: the PEPCAD-DES study. J Am Coll Cardiol 59(15):1377–1382PubMed Rittger H et al (2012) A randomized, multicenter, single-blinded trial comparing paclitaxel-coated balloon angioplasty with plain balloon angioplasty in drug-eluting stent restenosis: the PEPCAD-DES study. J Am Coll Cardiol 59(15):1377–1382PubMed
17.
Zurück zum Zitat Habara S et al (2013) A multicenter randomized comparison of paclitaxel-coated balloon catheter with conventional balloon angioplasty in patients with bare-metal stent restenosis and drug-eluting stent restenosis. Am Heart J 166(3):527–533PubMed Habara S et al (2013) A multicenter randomized comparison of paclitaxel-coated balloon catheter with conventional balloon angioplasty in patients with bare-metal stent restenosis and drug-eluting stent restenosis. Am Heart J 166(3):527–533PubMed
18.
Zurück zum Zitat Byrne RA et al (2013) Paclitaxel-eluting balloons, paclitaxel-eluting stents, and balloon angioplasty in patients with restenosis after implantation of a drug-eluting stent (ISAR-DESIRE 3): a randomised, open-label trial. Lancet 381(9865):461–467PubMed Byrne RA et al (2013) Paclitaxel-eluting balloons, paclitaxel-eluting stents, and balloon angioplasty in patients with restenosis after implantation of a drug-eluting stent (ISAR-DESIRE 3): a randomised, open-label trial. Lancet 381(9865):461–467PubMed
19.
Zurück zum Zitat Alfonso F et al (2015) A prospective randomized trial of drug-eluting balloons versus everolimus-eluting stents in patients with in-stent restenosis of drug-eluting stents: the RIBS IV randomized clinical trial. J Am Coll Cardiol 66(1):23–33PubMed Alfonso F et al (2015) A prospective randomized trial of drug-eluting balloons versus everolimus-eluting stents in patients with in-stent restenosis of drug-eluting stents: the RIBS IV randomized clinical trial. J Am Coll Cardiol 66(1):23–33PubMed
20.
Zurück zum Zitat Cortese B et al (2010) Paclitaxel-coated balloon versus drug-eluting stent during PCI of small coronary vessels, a prospective randomised clinical trial. The PICCOLETO study. Heart 96(16):1291–1296PubMed Cortese B et al (2010) Paclitaxel-coated balloon versus drug-eluting stent during PCI of small coronary vessels, a prospective randomised clinical trial. The PICCOLETO study. Heart 96(16):1291–1296PubMed
21.
Zurück zum Zitat Latib A et al (2012) A randomized multicenter study comparing a paclitaxel drug-eluting balloon with a paclitaxel-eluting stent in small coronary vessels: the BELLO (Balloon Elution and Late Loss Optimization) study. J Am Coll Cardiol 60(24):2473–2480PubMed Latib A et al (2012) A randomized multicenter study comparing a paclitaxel drug-eluting balloon with a paclitaxel-eluting stent in small coronary vessels: the BELLO (Balloon Elution and Late Loss Optimization) study. J Am Coll Cardiol 60(24):2473–2480PubMed
22.
Zurück zum Zitat Stella PR et al (2012) A multicenter randomized comparison of drug-eluting balloon plus bare-metal stent versus bare-metal stent versus drug-eluting stent in bifurcation lesions treated with a single-stenting technique: six-month angiographic and 12-month clinical results of the drug-eluting balloon in bifurcations trial. Catheter Cardiovasc Interv 80(7):1138–1146PubMed Stella PR et al (2012) A multicenter randomized comparison of drug-eluting balloon plus bare-metal stent versus bare-metal stent versus drug-eluting stent in bifurcation lesions treated with a single-stenting technique: six-month angiographic and 12-month clinical results of the drug-eluting balloon in bifurcations trial. Catheter Cardiovasc Interv 80(7):1138–1146PubMed
23.
Zurück zum Zitat Lee MS et al (2002) Cutting balloon angioplasty. J Invasive Cardiol 14(9):552–556PubMed Lee MS et al (2002) Cutting balloon angioplasty. J Invasive Cardiol 14(9):552–556PubMed
24.
Zurück zum Zitat Abdel-Wahab M et al (2013) High-speed rotational atherectomy before paclitaxel-eluting stent implantation in complex calcified coronary lesions: the randomized ROTAXUS (Rotational Atherectomy Prior to Taxus Stent Treatment for Complex Native Coronary Artery Disease) trial. JACC Cardiovasc Interv 6(1):10–19PubMed Abdel-Wahab M et al (2013) High-speed rotational atherectomy before paclitaxel-eluting stent implantation in complex calcified coronary lesions: the randomized ROTAXUS (Rotational Atherectomy Prior to Taxus Stent Treatment for Complex Native Coronary Artery Disease) trial. JACC Cardiovasc Interv 6(1):10–19PubMed
25.
Zurück zum Zitat Ali ZA et al (2017) Optical coherence tomography characterization of coronary lithoplasty for treatment of calcified lesions: first description. JACC Cardiovasc Imaging 10(8):897–906PubMed Ali ZA et al (2017) Optical coherence tomography characterization of coronary lithoplasty for treatment of calcified lesions: first description. JACC Cardiovasc Imaging 10(8):897–906PubMed
26.
Zurück zum Zitat Brinton TJ et al (2019) Feasibility of shockwave coronary intravascular lithotripsy for the treatment of calcified coronary stenoses. Circulation 139(6):834–836PubMed Brinton TJ et al (2019) Feasibility of shockwave coronary intravascular lithotripsy for the treatment of calcified coronary stenoses. Circulation 139(6):834–836PubMed
27.
Zurück zum Zitat Watkins S et al (2019) Intravascular lithotripsy to treat a severely underexpanded coronary stent. EuroIntervention 15(1):124–125PubMed Watkins S et al (2019) Intravascular lithotripsy to treat a severely underexpanded coronary stent. EuroIntervention 15(1):124–125PubMed
28.
Zurück zum Zitat Lassen JF et al (2018) Percutaneous coronary intervention for the left main stem and other bifurcation lesions: 12th consensus document from the European Bifurcation Club. EuroIntervention 13(13):1540–1553PubMed Lassen JF et al (2018) Percutaneous coronary intervention for the left main stem and other bifurcation lesions: 12th consensus document from the European Bifurcation Club. EuroIntervention 13(13):1540–1553PubMed
29.
Zurück zum Zitat Nef HM et al (2016) Bifurcation lesions: how should they be assessed and treated? Herz 41(7):572–578PubMed Nef HM et al (2016) Bifurcation lesions: how should they be assessed and treated? Herz 41(7):572–578PubMed
31.
Zurück zum Zitat Galassi AR et al (2019) Percutaneous recanalisation of chronic total occlusions: 2019 consensus document from the EuroCTO Club. EuroIntervention 15(2):198–208PubMed Galassi AR et al (2019) Percutaneous recanalisation of chronic total occlusions: 2019 consensus document from the EuroCTO Club. EuroIntervention 15(2):198–208PubMed
32.
Zurück zum Zitat Morino Y et al (2011) Predicting successful guidewire crossing through chronic total occlusion of native coronary lesions within 30 minutes: the J‑CTO (Multicenter CTO Registry in Japan) score as a difficulty grading and time assessment tool. JACC Cardiovasc Interv 4(2):213–221PubMed Morino Y et al (2011) Predicting successful guidewire crossing through chronic total occlusion of native coronary lesions within 30 minutes: the J‑CTO (Multicenter CTO Registry in Japan) score as a difficulty grading and time assessment tool. JACC Cardiovasc Interv 4(2):213–221PubMed
33.
Zurück zum Zitat Oreglia JA et al (2018) Dual lumen microcatheters for complex percutaneous coronary interventions. Cardiovasc Revasc Med 19(3 Pt A):298–305PubMed Oreglia JA et al (2018) Dual lumen microcatheters for complex percutaneous coronary interventions. Cardiovasc Revasc Med 19(3 Pt A):298–305PubMed
34.
Zurück zum Zitat Maeremans J et al (2016) The hybrid algorithm for treating chronic total occlusions in Europe: the RECHARGE registry. J Am Coll Cardiol 68(18):1958–1970PubMed Maeremans J et al (2016) The hybrid algorithm for treating chronic total occlusions in Europe: the RECHARGE registry. J Am Coll Cardiol 68(18):1958–1970PubMed
35.
Zurück zum Zitat Albiero R et al (2004) Cutting balloon versus conventional balloon angioplasty for the treatment of in-stent restenosis: results of the restenosis cutting balloon evaluation trial (RESCUT). J Am Coll Cardiol 43(6):943–949PubMed Albiero R et al (2004) Cutting balloon versus conventional balloon angioplasty for the treatment of in-stent restenosis: results of the restenosis cutting balloon evaluation trial (RESCUT). J Am Coll Cardiol 43(6):943–949PubMed
36.
Zurück zum Zitat Giacoppo D et al (2020) Drug-coated balloon angioplasty versus drug-eluting stent implantation in patients with coronary stent restenosis. J Am Coll Cardiol 75(21):2664–2678PubMed Giacoppo D et al (2020) Drug-coated balloon angioplasty versus drug-eluting stent implantation in patients with coronary stent restenosis. J Am Coll Cardiol 75(21):2664–2678PubMed
37.
Zurück zum Zitat Leborgne L et al (2003) Effect of direct stenting on clinical outcome in patients treated with percutaneous coronary intervention on saphenous vein graft. Am Heart J 146(3):501–506PubMed Leborgne L et al (2003) Effect of direct stenting on clinical outcome in patients treated with percutaneous coronary intervention on saphenous vein graft. Am Heart J 146(3):501–506PubMed
38.
Zurück zum Zitat Okabe T et al (2008) Can direct stenting in selected saphenous vein graft lesions be considered an alternative to percutaneous intervention with a distal protection device? Catheter Cardiovasc Interv 72(6):799–803PubMed Okabe T et al (2008) Can direct stenting in selected saphenous vein graft lesions be considered an alternative to percutaneous intervention with a distal protection device? Catheter Cardiovasc Interv 72(6):799–803PubMed
39.
Zurück zum Zitat Baim DS et al (2002) Randomized trial of a distal embolic protection device during percutaneous intervention of saphenous vein aorto-coronary bypass grafts. Circulation 105(11):1285–1290PubMed Baim DS et al (2002) Randomized trial of a distal embolic protection device during percutaneous intervention of saphenous vein aorto-coronary bypass grafts. Circulation 105(11):1285–1290PubMed
40.
Zurück zum Zitat Brennan JM et al (2015) Three-year outcomes associated with embolic protection in saphenous vein graft intervention: results in 49 325 senior patients in the Medicare-linked National Cardiovascular Data Registry CathPCI Registry. Circ Cardiovasc Interv 8(3):e1403PubMed Brennan JM et al (2015) Three-year outcomes associated with embolic protection in saphenous vein graft intervention: results in 49 325 senior patients in the Medicare-linked National Cardiovascular Data Registry CathPCI Registry. Circ Cardiovasc Interv 8(3):e1403PubMed
42.
Zurück zum Zitat Ng AK, Jim M-H (2016) Percutaneous coronary intervention for bifurcation: how can we outperform the provisional strategy? Clin Cardiol 39(11):684–691PubMedPubMedCentral Ng AK, Jim M-H (2016) Percutaneous coronary intervention for bifurcation: how can we outperform the provisional strategy? Clin Cardiol 39(11):684–691PubMedPubMedCentral
43.
Zurück zum Zitat De Maria GL, Scarsini R, Banning AP (2019) Management of calcific coronary artery lesions: is it time to change our interventional therapeutic approach? JACC Cardiovasc Interv 12(15):1465–1478PubMed De Maria GL, Scarsini R, Banning AP (2019) Management of calcific coronary artery lesions: is it time to change our interventional therapeutic approach? JACC Cardiovasc Interv 12(15):1465–1478PubMed
44.
Zurück zum Zitat Genereux P et al (2017) Two-year outcomes after percutaneous coronary intervention of calcified lesions with drug-eluting stents. Int J Cardiol 231:61–67PubMed Genereux P et al (2017) Two-year outcomes after percutaneous coronary intervention of calcified lesions with drug-eluting stents. Int J Cardiol 231:61–67PubMed
46.
Zurück zum Zitat Ibanez B et al (2018) 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 39(2):119–177PubMed Ibanez B et al (2018) 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 39(2):119–177PubMed
48.
Zurück zum Zitat Jolicoeur EM et al (2013) A phase II, sham-controlled, double-blinded study testing the safety and efficacy of the coronary sinus reducer in patients with refractory angina: study protocol for a randomized controlled trial. Trials 14:46PubMedPubMedCentral Jolicoeur EM et al (2013) A phase II, sham-controlled, double-blinded study testing the safety and efficacy of the coronary sinus reducer in patients with refractory angina: study protocol for a randomized controlled trial. Trials 14:46PubMedPubMedCentral
49.
Zurück zum Zitat Gallone G et al (2019) Coronary sinus reducer implantation to reduce the ischemic burden in refractory angina. JACC Cardiovasc Interv 12(2):e11–e13PubMed Gallone G et al (2019) Coronary sinus reducer implantation to reduce the ischemic burden in refractory angina. JACC Cardiovasc Interv 12(2):e11–e13PubMed
50.
Zurück zum Zitat Giannini F et al (2019) Patterns of regional myocardial perfusion following coronary sinus reducer implantation. Circ Cardiovasc Imaging 12(9):e9148PubMedPubMedCentral Giannini F et al (2019) Patterns of regional myocardial perfusion following coronary sinus reducer implantation. Circ Cardiovasc Imaging 12(9):e9148PubMedPubMedCentral
51.
Zurück zum Zitat Parisi AF, Folland ED, Hartigan P (1992) A comparison of angioplasty with medical therapy in the treatment of single-vessel coronary artery disease. N Engl J Med 326(1):10–16PubMed Parisi AF, Folland ED, Hartigan P (1992) A comparison of angioplasty with medical therapy in the treatment of single-vessel coronary artery disease. N Engl J Med 326(1):10–16PubMed
52.
Zurück zum Zitat Pepine CJ et al (1994) The Asymptomatic Cardiac Ischemia Pilot (ACIP) study: design of a randomized clinical trial, baseline data and implications for a long-term outcome trial. J Am Coll Cardiol 24(1):1–10PubMed Pepine CJ et al (1994) The Asymptomatic Cardiac Ischemia Pilot (ACIP) study: design of a randomized clinical trial, baseline data and implications for a long-term outcome trial. J Am Coll Cardiol 24(1):1–10PubMed
53.
Zurück zum Zitat RITA‑2 trial participants (1997) Coronary angioplasty versus medical therapy for angina: the second Randomised Intervention Treatment of Angina (RITA-2) trial. Lancet 350(9076):461–468 RITA‑2 trial participants (1997) Coronary angioplasty versus medical therapy for angina: the second Randomised Intervention Treatment of Angina (RITA-2) trial. Lancet 350(9076):461–468
54.
Zurück zum Zitat Bucher HC et al (2000) Percutaneous transluminal coronary angioplasty versus medical treatment for non-acute coronary heart disease: meta-analysis of randomised controlled trials. BMJ 321(7253):73–77PubMedPubMedCentral Bucher HC et al (2000) Percutaneous transluminal coronary angioplasty versus medical treatment for non-acute coronary heart disease: meta-analysis of randomised controlled trials. BMJ 321(7253):73–77PubMedPubMedCentral
55.
Zurück zum Zitat Pfisterer M (2004) Long-term outcome in elderly patients with chronic angina managed invasively versus by optimized medical therapy: four-year follow-up of the randomized Trial of Invasive versus Medical therapy in Elderly patients (TIME). Circulation 110(10):1213–1218PubMed Pfisterer M (2004) Long-term outcome in elderly patients with chronic angina managed invasively versus by optimized medical therapy: four-year follow-up of the randomized Trial of Invasive versus Medical therapy in Elderly patients (TIME). Circulation 110(10):1213–1218PubMed
56.
Zurück zum Zitat Windecker S et al (2014) Revascularisation versus medical treatment in patients with stable coronary artery disease: network meta-analysis. BMJ 348:g3859PubMedPubMedCentral Windecker S et al (2014) Revascularisation versus medical treatment in patients with stable coronary artery disease: network meta-analysis. BMJ 348:g3859PubMedPubMedCentral
57.
Zurück zum Zitat Bangalore S et al (2020) Routine revascularization versus initial medical therapy for stable ischemic heart disease: a systematic review and meta-analysis of randomized trials. Circulation 142(9):841–857PubMed Bangalore S et al (2020) Routine revascularization versus initial medical therapy for stable ischemic heart disease: a systematic review and meta-analysis of randomized trials. Circulation 142(9):841–857PubMed
58.
Zurück zum Zitat Al-Lamee R et al (2018) Percutaneous coronary intervention in stable angina (ORBITA): a double-blind, randomised controlled trial. Lancet 391(10115):31–40PubMed Al-Lamee R et al (2018) Percutaneous coronary intervention in stable angina (ORBITA): a double-blind, randomised controlled trial. Lancet 391(10115):31–40PubMed
59.
Zurück zum Zitat De Bruyne B et al (2012) Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease. N Engl J Med 367(11):991–1001PubMed De Bruyne B et al (2012) Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease. N Engl J Med 367(11):991–1001PubMed
60.
Zurück zum Zitat Xaplanteris P et al (2018) Five-year outcomes with PCI guided by fractional flow reserve. N Engl J Med 379(3):250–259PubMed Xaplanteris P et al (2018) Five-year outcomes with PCI guided by fractional flow reserve. N Engl J Med 379(3):250–259PubMed
61.
Zurück zum Zitat Boden WE et al (2007) Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med 356(15):1503–1516PubMed Boden WE et al (2007) Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med 356(15):1503–1516PubMed
62.
Zurück zum Zitat Shaw LJ et al (2008) Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy. Circulation 117(10):1283–1291PubMed Shaw LJ et al (2008) Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy. Circulation 117(10):1283–1291PubMed
63.
Zurück zum Zitat Maron DJ et al (2020) Initial invasive or conservative strategy for stable coronary disease. N Engl J Med 382(15):1395–1407PubMedPubMedCentral Maron DJ et al (2020) Initial invasive or conservative strategy for stable coronary disease. N Engl J Med 382(15):1395–1407PubMedPubMedCentral
64.
Zurück zum Zitat De Bruyne B et al (2014) Fractional flow reserve-guided PCI for stable coronary artery disease. N Engl J Med 371(13):1208–1217PubMed De Bruyne B et al (2014) Fractional flow reserve-guided PCI for stable coronary artery disease. N Engl J Med 371(13):1208–1217PubMed
65.
Zurück zum Zitat Garcia S et al (2013) Outcomes after complete versus incomplete revascularization of patients with multivessel coronary artery disease: a meta-analysis of 89,883 patients enrolled in randomized clinical trials and observational studies. J Am Coll Cardiol 62(16):1421–1431PubMed Garcia S et al (2013) Outcomes after complete versus incomplete revascularization of patients with multivessel coronary artery disease: a meta-analysis of 89,883 patients enrolled in randomized clinical trials and observational studies. J Am Coll Cardiol 62(16):1421–1431PubMed
66.
Zurück zum Zitat Farooq V et al (2013) Quantification of incomplete revascularization and its association with five-year mortality in the synergy between percutaneous coronary intervention with taxus and cardiac surgery (SYNTAX) trial validation of the residual SYNTAX score. Circulation 128(2):141–151PubMed Farooq V et al (2013) Quantification of incomplete revascularization and its association with five-year mortality in the synergy between percutaneous coronary intervention with taxus and cardiac surgery (SYNTAX) trial validation of the residual SYNTAX score. Circulation 128(2):141–151PubMed
67.
Zurück zum Zitat Park SJ et al (2015) Trial of everolimus-eluting stents or bypass surgery for coronary disease. N Engl J Med 372(13):1204–1212PubMed Park SJ et al (2015) Trial of everolimus-eluting stents or bypass surgery for coronary disease. N Engl J Med 372(13):1204–1212PubMed
68.
Zurück zum Zitat Head SJ et al (2018) Mortality after coronary artery bypass grafting versus percutaneous coronary intervention with stenting for coronary artery disease: a pooled analysis of individual patient data. Lancet 391(10124):939–948PubMed Head SJ et al (2018) Mortality after coronary artery bypass grafting versus percutaneous coronary intervention with stenting for coronary artery disease: a pooled analysis of individual patient data. Lancet 391(10124):939–948PubMed
69.
Zurück zum Zitat Tonino PA et al (2009) Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. N Engl J Med 360(3):213–224PubMed Tonino PA et al (2009) Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. N Engl J Med 360(3):213–224PubMed
70.
Zurück zum Zitat Gaede L et al (2019) Coronary angiography with pressure wire and fractional flow reserve: state of the art in the diagnosis of coronary stenosis. Dtsch Arztebl Int 116(12):205–211PubMedPubMedCentral Gaede L et al (2019) Coronary angiography with pressure wire and fractional flow reserve: state of the art in the diagnosis of coronary stenosis. Dtsch Arztebl Int 116(12):205–211PubMedPubMedCentral
71.
Zurück zum Zitat Ahn JM et al (2015) Randomized trial of stents versus bypass surgery for left main coronary artery disease: 5‑year outcomes of the PRECOMBAT study. J Am Coll Cardiol 65(20):2198–2206PubMed Ahn JM et al (2015) Randomized trial of stents versus bypass surgery for left main coronary artery disease: 5‑year outcomes of the PRECOMBAT study. J Am Coll Cardiol 65(20):2198–2206PubMed
72.
Zurück zum Zitat Makikallio T et al (2016) Percutaneous coronary angioplasty versus coronary artery bypass grafting in treatment of unprotected left main stenosis (NOBLE): a prospective, randomised, open-label, non-inferiority trial. Lancet 388(10061):2743–2752PubMed Makikallio T et al (2016) Percutaneous coronary angioplasty versus coronary artery bypass grafting in treatment of unprotected left main stenosis (NOBLE): a prospective, randomised, open-label, non-inferiority trial. Lancet 388(10061):2743–2752PubMed
73.
Zurück zum Zitat Mohr FW et al (2013) Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5‑year follow-up of the randomised, clinical SYNTAX trial. Lancet 381(9867):629–638PubMed Mohr FW et al (2013) Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5‑year follow-up of the randomised, clinical SYNTAX trial. Lancet 381(9867):629–638PubMed
74.
Zurück zum Zitat Stone GW et al (2016) Everolimus-eluting stents or bypass surgery for left main coronary artery disease. N Engl J Med 375(23):2223–2235PubMed Stone GW et al (2016) Everolimus-eluting stents or bypass surgery for left main coronary artery disease. N Engl J Med 375(23):2223–2235PubMed
75.
Zurück zum Zitat Giacoppo D et al (2017) Percutaneous coronary intervention vs coronary artery bypass grafting in patients with left main coronary artery stenosis: a systematic review and meta-analysis. JAMA Cardiol 2(10):1079–1088PubMedPubMedCentral Giacoppo D et al (2017) Percutaneous coronary intervention vs coronary artery bypass grafting in patients with left main coronary artery stenosis: a systematic review and meta-analysis. JAMA Cardiol 2(10):1079–1088PubMedPubMedCentral
76.
77.
Zurück zum Zitat Brener SJ et al (2004) Propensity analysis of long-term survival after surgical or percutaneous revascularization in patients with multivessel coronary artery disease and high-risk features. Circulation 109(19):2290–2295PubMed Brener SJ et al (2004) Propensity analysis of long-term survival after surgical or percutaneous revascularization in patients with multivessel coronary artery disease and high-risk features. Circulation 109(19):2290–2295PubMed
78.
Zurück zum Zitat Hoffman SN et al (2003) A meta-analysis of randomized controlled trials comparing coronary artery bypass graft with percutaneous transluminal coronary angioplasty: one- to eight-year outcomes. J Am Coll Cardiol 41(8):1293–1304PubMed Hoffman SN et al (2003) A meta-analysis of randomized controlled trials comparing coronary artery bypass graft with percutaneous transluminal coronary angioplasty: one- to eight-year outcomes. J Am Coll Cardiol 41(8):1293–1304PubMed
79.
Zurück zum Zitat Farkouh ME et al (2012) Strategies for multivessel revascularization in patients with diabetes. N Engl J Med 367(25):2375–2384PubMed Farkouh ME et al (2012) Strategies for multivessel revascularization in patients with diabetes. N Engl J Med 367(25):2375–2384PubMed
80.
Zurück zum Zitat Nashef SA et al (2012) EuroSCORE II. Eur J Cardiothorac Surg 41(4):734–744 (discussion 744–5)PubMed Nashef SA et al (2012) EuroSCORE II. Eur J Cardiothorac Surg 41(4):734–744 (discussion 744–5)PubMed
81.
Zurück zum Zitat Shahian DM et al (2009) The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 1 – coronary artery bypass grafting surgery. Ann Thorac Surg 88(1 Suppl):S2–S22PubMed Shahian DM et al (2009) The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 1 – coronary artery bypass grafting surgery. Ann Thorac Surg 88(1 Suppl):S2–S22PubMed
82.
Zurück zum Zitat Velicki L et al (2014) Clinical performance of the EuroSCORE II compared with the previous EuroSCORE iterations. Thorac Cardiovasc Surg 62(4):288–297PubMed Velicki L et al (2014) Clinical performance of the EuroSCORE II compared with the previous EuroSCORE iterations. Thorac Cardiovasc Surg 62(4):288–297PubMed
83.
Zurück zum Zitat Savage MP et al (1997) Stent placement compared with balloon angioplasty for obstructed coronary bypass grafts. N Engl J Med 337(11):740–747PubMed Savage MP et al (1997) Stent placement compared with balloon angioplasty for obstructed coronary bypass grafts. N Engl J Med 337(11):740–747PubMed
84.
Zurück zum Zitat Al-Lamee R et al (2010) Clinical and angiographic outcomes after percutaneous recanalization of chronic total saphenous vein graft occlusion using modern techniques. Am J Cardiol 106(12):1721–1727PubMed Al-Lamee R et al (2010) Clinical and angiographic outcomes after percutaneous recanalization of chronic total saphenous vein graft occlusion using modern techniques. Am J Cardiol 106(12):1721–1727PubMed
85.
Zurück zum Zitat Galassi AR et al (2016) Appropriateness of percutaneous revascularization of coronary chronic total occlusions: an overview. Eur Heart J 37(35):2692–2700PubMed Galassi AR et al (2016) Appropriateness of percutaneous revascularization of coronary chronic total occlusions: an overview. Eur Heart J 37(35):2692–2700PubMed
86.
Zurück zum Zitat Jeroudi OM et al (2014) Prevalence and management of coronary chronic total occlusions in a tertiary Veterans Affairs hospital. Catheter Cardiovasc Interv 84(4):637–643PubMed Jeroudi OM et al (2014) Prevalence and management of coronary chronic total occlusions in a tertiary Veterans Affairs hospital. Catheter Cardiovasc Interv 84(4):637–643PubMed
87.
Zurück zum Zitat Christakopoulos GE et al (2015) Meta-analysis of clinical outcomes of patients who underwent percutaneous coronary interventions for chronic total occlusions. Am J Cardiol 115(10):1367–1375PubMed Christakopoulos GE et al (2015) Meta-analysis of clinical outcomes of patients who underwent percutaneous coronary interventions for chronic total occlusions. Am J Cardiol 115(10):1367–1375PubMed
88.
Zurück zum Zitat Lee SW et al (2019) Randomized trial evaluating percutaneous coronary intervention for the treatment of chronic total occlusion. Circulation 139(14):1674–1683PubMed Lee SW et al (2019) Randomized trial evaluating percutaneous coronary intervention for the treatment of chronic total occlusion. Circulation 139(14):1674–1683PubMed
89.
Zurück zum Zitat Werner GS et al (2018) A randomized multicentre trial to compare revascularization with optimal medical therapy for the treatment of chronic total coronary occlusions. Eur Heart J 39(26):2484–2493PubMed Werner GS et al (2018) A randomized multicentre trial to compare revascularization with optimal medical therapy for the treatment of chronic total coronary occlusions. Eur Heart J 39(26):2484–2493PubMed
90.
Zurück zum Zitat Morino Y et al (2011) Predicting successful guidewire crossing through chronic total occlusion of native coronary lesions within 30 minutes: the J‑CTO (Multicenter CTO Registry in Japan) score as a difficulty grading and time assessment tool. JACC Cardiovasc Interv 4(2):213–221PubMed Morino Y et al (2011) Predicting successful guidewire crossing through chronic total occlusion of native coronary lesions within 30 minutes: the J‑CTO (Multicenter CTO Registry in Japan) score as a difficulty grading and time assessment tool. JACC Cardiovasc Interv 4(2):213–221PubMed
91.
Zurück zum Zitat Moscucci M, Eagle KA (2004) Coronary revascularization before noncardiac surgery. N Engl J Med 351:2861–2863PubMed Moscucci M, Eagle KA (2004) Coronary revascularization before noncardiac surgery. N Engl J Med 351:2861–2863PubMed
92.
Zurück zum Zitat Rissanen TT et al (2019) Drug-coated balloon for treatment of de-novo coronary artery lesions in patients with high bleeding risk (DEBUT): a single-blind, randomised, non-inferiority trial. Lancet 394(10194):230–239PubMed Rissanen TT et al (2019) Drug-coated balloon for treatment of de-novo coronary artery lesions in patients with high bleeding risk (DEBUT): a single-blind, randomised, non-inferiority trial. Lancet 394(10194):230–239PubMed
93.
Zurück zum Zitat Urban P et al (2015) Polymer-free drug-coated coronary stents in patients at high bleeding risk. N Engl J Med 373(21):2038–2047PubMed Urban P et al (2015) Polymer-free drug-coated coronary stents in patients at high bleeding risk. N Engl J Med 373(21):2038–2047PubMed
94.
Zurück zum Zitat Varenne O et al (2018) Drug-eluting stents in elderly patients with coronary artery disease (SENIOR): a randomised single-blind trial. Lancet 391(10115):41–50PubMed Varenne O et al (2018) Drug-eluting stents in elderly patients with coronary artery disease (SENIOR): a randomised single-blind trial. Lancet 391(10115):41–50PubMed
95.
Zurück zum Zitat Jolly SS et al (2011) Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomised, parallel group, multicentre trial. Lancet 377(9775):1409–1420PubMed Jolly SS et al (2011) Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomised, parallel group, multicentre trial. Lancet 377(9775):1409–1420PubMed
96.
Zurück zum Zitat Rao SV et al (2014) A registry-based randomized trial comparing radial and femoral approaches in women undergoing percutaneous coronary intervention: the SAFE-PCI for Women (Study of Access Site for Enhancement of PCI for Women) trial. JACC Cardiovasc Interv 7(8):857–867PubMed Rao SV et al (2014) A registry-based randomized trial comparing radial and femoral approaches in women undergoing percutaneous coronary intervention: the SAFE-PCI for Women (Study of Access Site for Enhancement of PCI for Women) trial. JACC Cardiovasc Interv 7(8):857–867PubMed
97.
Zurück zum Zitat Valgimigli M et al (2015) Radial versus femoral access in patients with acute coronary syndromes undergoing invasive management: a randomised multicentre trial. Lancet 385(9986):2465–2476PubMed Valgimigli M et al (2015) Radial versus femoral access in patients with acute coronary syndromes undergoing invasive management: a randomised multicentre trial. Lancet 385(9986):2465–2476PubMed
98.
Zurück zum Zitat Ando G, Capodanno D (2016) Radial access reduces mortality in patients with acute coronary syndromes: results from an updated trial sequential analysis of randomized trials. JACC Cardiovasc Interv 9(7):660–670PubMed Ando G, Capodanno D (2016) Radial access reduces mortality in patients with acute coronary syndromes: results from an updated trial sequential analysis of randomized trials. JACC Cardiovasc Interv 9(7):660–670PubMed
99.
Zurück zum Zitat Valgimigli M et al (2018) Radial versus femoral access and bivalirudin versus unfractionated heparin in invasively managed patients with acute coronary syndrome (MATRIX): final 1‑year results of a multicentre, randomised controlled trial. Lancet 392(10150):835–848PubMed Valgimigli M et al (2018) Radial versus femoral access and bivalirudin versus unfractionated heparin in invasively managed patients with acute coronary syndrome (MATRIX): final 1‑year results of a multicentre, randomised controlled trial. Lancet 392(10150):835–848PubMed
100.
Zurück zum Zitat Le May M (2019) The safety and afficacy of femoral access vs radial access in STEMI. In: ACC Congr Le May M (2019) The safety and afficacy of femoral access vs radial access in STEMI. In: ACC Congr
101.
Zurück zum Zitat Sgarbossa EB, Birnbaum Y, Parrillo JE (2001) Electrocardiographic diagnosis of acute myocardial infarction: current concepts for the clinician. Am Heart J 141(4):507–517PubMed Sgarbossa EB, Birnbaum Y, Parrillo JE (2001) Electrocardiographic diagnosis of acute myocardial infarction: current concepts for the clinician. Am Heart J 141(4):507–517PubMed
102.
Zurück zum Zitat de Winter RJ et al (2008) A new ECG sign of proximal LAD occlusion. n Engl J Med 359:2071–2073PubMed de Winter RJ et al (2008) A new ECG sign of proximal LAD occlusion. n Engl J Med 359:2071–2073PubMed
103.
Zurück zum Zitat Kurisu S et al (2004) Electrocardiographic features in patients with acute myocardial infarction associated with left main coronary artery occlusion. Heart 90:1059–1060PubMedPubMedCentral Kurisu S et al (2004) Electrocardiographic features in patients with acute myocardial infarction associated with left main coronary artery occlusion. Heart 90:1059–1060PubMedPubMedCentral
104.
Zurück zum Zitat Roffi M et al (2016) 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC). Eur Heart J 37(3):267–315PubMed Roffi M et al (2016) 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC). Eur Heart J 37(3):267–315PubMed
105.
Zurück zum Zitat Thiele H et al (2012) Optimal timing of invasive angiography in stable non-ST-elevation myocardial infarction: the Leipzig Immediate versus early and late PercutaneouS coronary Intervention triAl in NSTEMI (LIPSIA-NSTEMI Trial). Eur Heart J 33(16):2035–2043PubMed Thiele H et al (2012) Optimal timing of invasive angiography in stable non-ST-elevation myocardial infarction: the Leipzig Immediate versus early and late PercutaneouS coronary Intervention triAl in NSTEMI (LIPSIA-NSTEMI Trial). Eur Heart J 33(16):2035–2043PubMed
106.
Zurück zum Zitat Kastrati A et al (2011) Abciximab and heparin versus bivalirudin for non-ST-elevation myocardial infarction. N Engl J Med 365(21):1980–1989PubMed Kastrati A et al (2011) Abciximab and heparin versus bivalirudin for non-ST-elevation myocardial infarction. N Engl J Med 365(21):1980–1989PubMed
107.
Zurück zum Zitat Virmani R et al (2006) Pathology of the vulnerable plaque. J Am Coll Cardiol 47(8 Suppl):C13–C18PubMed Virmani R et al (2006) Pathology of the vulnerable plaque. J Am Coll Cardiol 47(8 Suppl):C13–C18PubMed
108.
Zurück zum Zitat Cheruvu PK et al (2007) Frequency and distribution of thin-cap fibroatheroma and ruptured plaques in human coronary arteries: a pathologic study. J Am Coll Cardiol 50(10):940–949PubMed Cheruvu PK et al (2007) Frequency and distribution of thin-cap fibroatheroma and ruptured plaques in human coronary arteries: a pathologic study. J Am Coll Cardiol 50(10):940–949PubMed
109.
Zurück zum Zitat Goldstein JA et al (2000) Multiple complex coronary plaques in patients with acute myocardial infarction. N Engl J Med 343(13):915–922PubMed Goldstein JA et al (2000) Multiple complex coronary plaques in patients with acute myocardial infarction. N Engl J Med 343(13):915–922PubMed
110.
Zurück zum Zitat Kerensky RA et al (2002) Revisiting the culprit lesion in non-Q-wave myocardial infarction. Results from the VANQWISH trial angiographic core laboratory. J Am Coll Cardiol 39(9):1456–1463PubMed Kerensky RA et al (2002) Revisiting the culprit lesion in non-Q-wave myocardial infarction. Results from the VANQWISH trial angiographic core laboratory. J Am Coll Cardiol 39(9):1456–1463PubMed
111.
Zurück zum Zitat Shishehbor MH et al (2007) In unstable angina or non-ST-segment acute coronary syndrome, should patients with multivessel coronary artery disease undergo multivessel or culprit-only stenting? J Am Coll Cardiol 49(8):849–854PubMed Shishehbor MH et al (2007) In unstable angina or non-ST-segment acute coronary syndrome, should patients with multivessel coronary artery disease undergo multivessel or culprit-only stenting? J Am Coll Cardiol 49(8):849–854PubMed
112.
Zurück zum Zitat Smits PC et al (2017) Fractional flow reserve-guided multivessel angioplasty in myocardial infarction. N Engl J Med 376(13):1234–1244PubMed Smits PC et al (2017) Fractional flow reserve-guided multivessel angioplasty in myocardial infarction. N Engl J Med 376(13):1234–1244PubMed
113.
Zurück zum Zitat Cannon CP et al (2001) Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N Engl J Med 344(25):1879–1887PubMed Cannon CP et al (2001) Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N Engl J Med 344(25):1879–1887PubMed
114.
Zurück zum Zitat Fox KA et al (2005) 5‑year outcome of an interventional strategy in non-ST-elevation acute coronary syndrome: the British Heart Foundation RITA 3 randomised trial. Lancet 366(9489):914–920PubMed Fox KA et al (2005) 5‑year outcome of an interventional strategy in non-ST-elevation acute coronary syndrome: the British Heart Foundation RITA 3 randomised trial. Lancet 366(9489):914–920PubMed
115.
Zurück zum Zitat Wallentin L et al (2000) Outcome at 1 year after an invasive compared with a non-invasive strategy in unstable coronary-artery disease: the FRISC II invasive randomised trial. Lancet 356(9223):9–16PubMed Wallentin L et al (2000) Outcome at 1 year after an invasive compared with a non-invasive strategy in unstable coronary-artery disease: the FRISC II invasive randomised trial. Lancet 356(9223):9–16PubMed
116.
Zurück zum Zitat Curtis JP et al (2009) All-cause readmission and repeat revascularization after percutaneous coronary intervention in a cohort of medicare patients. J Am Coll Cardiol 54(10):903–907PubMed Curtis JP et al (2009) All-cause readmission and repeat revascularization after percutaneous coronary intervention in a cohort of medicare patients. J Am Coll Cardiol 54(10):903–907PubMed
117.
Zurück zum Zitat Genereux P et al (2012) Quantification and impact of untreated coronary artery disease after percutaneous coronary intervention: the residual SYNTAX (Synergy Between PCI with Taxus and Cardiac Surgery) score. J Am Coll Cardiol 59(24):2165–2174PubMedPubMedCentral Genereux P et al (2012) Quantification and impact of untreated coronary artery disease after percutaneous coronary intervention: the residual SYNTAX (Synergy Between PCI with Taxus and Cardiac Surgery) score. J Am Coll Cardiol 59(24):2165–2174PubMedPubMedCentral
118.
Zurück zum Zitat Ben-Gal Y et al (2010) Surgical versus percutaneous revascularization for multivessel disease in patients with acute coronary syndromes: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial. JACC Cardiovasc Interv 3(10):1059–1067PubMed Ben-Gal Y et al (2010) Surgical versus percutaneous revascularization for multivessel disease in patients with acute coronary syndromes: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial. JACC Cardiovasc Interv 3(10):1059–1067PubMed
119.
Zurück zum Zitat Ranasinghe I et al (2011) Risk stratification in the setting of non-ST elevation acute coronary syndromes 1999–2007. Am J Cardiol 108(5):617–624PubMed Ranasinghe I et al (2011) Risk stratification in the setting of non-ST elevation acute coronary syndromes 1999–2007. Am J Cardiol 108(5):617–624PubMed
120.
Zurück zum Zitat Andersen HR et al (2003) A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction. N Engl J Med 349(8):733–742PubMed Andersen HR et al (2003) A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction. N Engl J Med 349(8):733–742PubMed
121.
Zurück zum Zitat Widimsky P et al (2003) Long distance transport for primary angioplasty vs immediate thrombolysis in acute myocardial infarction. Final results of the randomized national multicentre trial—PRAGUE‑2. Eur Heart J 24(1):94–104PubMed Widimsky P et al (2003) Long distance transport for primary angioplasty vs immediate thrombolysis in acute myocardial infarction. Final results of the randomized national multicentre trial—PRAGUE‑2. Eur Heart J 24(1):94–104PubMed
122.
Zurück zum Zitat Keeley EC, Boura JA, Grines CL (2003) Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet 361(9351):13–20PubMed Keeley EC, Boura JA, Grines CL (2003) Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet 361(9351):13–20PubMed
123.
Zurück zum Zitat Zijlstra F et al (1999) Long-term benefit of primary angioplasty as compared with thrombolytic therapy for acute myocardial infarction. N Engl J Med 341(19):1413–1419PubMed Zijlstra F et al (1999) Long-term benefit of primary angioplasty as compared with thrombolytic therapy for acute myocardial infarction. N Engl J Med 341(19):1413–1419PubMed
124.
Zurück zum Zitat Scholz KH et al (2018) Impact of treatment delay on mortality in ST-segment elevation myocardial infarction (STEMI) patients presenting with and without haemodynamic instability: results from the German prospective, multicentre FITT-STEMI trial. Eur Heart J 39(13):1065–1074PubMedPubMedCentral Scholz KH et al (2018) Impact of treatment delay on mortality in ST-segment elevation myocardial infarction (STEMI) patients presenting with and without haemodynamic instability: results from the German prospective, multicentre FITT-STEMI trial. Eur Heart J 39(13):1065–1074PubMedPubMedCentral
125.
Zurück zum Zitat Borgia F et al (2010) Early routine percutaneous coronary intervention after fibrinolysis vs. standard therapy in ST-segment elevation myocardial infarction: a meta-analysis. Eur Heart J 31(17):2156–2169PubMed Borgia F et al (2010) Early routine percutaneous coronary intervention after fibrinolysis vs. standard therapy in ST-segment elevation myocardial infarction: a meta-analysis. Eur Heart J 31(17):2156–2169PubMed
126.
Zurück zum Zitat D’Souza SP et al (2011) Routine early coronary angioplasty versus ischaemia-guided angioplasty after thrombolysis in acute ST-elevation myocardial infarction: a meta-analysis. Eur Heart J 32(8):972–982PubMed D’Souza SP et al (2011) Routine early coronary angioplasty versus ischaemia-guided angioplasty after thrombolysis in acute ST-elevation myocardial infarction: a meta-analysis. Eur Heart J 32(8):972–982PubMed
127.
Zurück zum Zitat Hochman JS et al (2006) Coronary intervention for persistent occlusion after myocardial infarction. N Engl J Med 355(23):2395–2407PubMedPubMedCentral Hochman JS et al (2006) Coronary intervention for persistent occlusion after myocardial infarction. N Engl J Med 355(23):2395–2407PubMedPubMedCentral
128.
Zurück zum Zitat Engstrom T et al (2015) Complete revascularisation versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI-3-PRIMULTI): an open-label, randomised controlled trial. Lancet 386(9994):665–671PubMed Engstrom T et al (2015) Complete revascularisation versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI-3-PRIMULTI): an open-label, randomised controlled trial. Lancet 386(9994):665–671PubMed
129.
Zurück zum Zitat Kelly DJ et al (2013) Complete Versus culprit-Lesion only PRimary PCI Trial (CVLPRIT): a multicentre trial testing management strategies when multivessel disease is detected at the time of primary PCI: rationale and design. EuroIntervention 8(10):1190–1198PubMed Kelly DJ et al (2013) Complete Versus culprit-Lesion only PRimary PCI Trial (CVLPRIT): a multicentre trial testing management strategies when multivessel disease is detected at the time of primary PCI: rationale and design. EuroIntervention 8(10):1190–1198PubMed
130.
Zurück zum Zitat Wald DS et al (2013) Randomized trial of preventive angioplasty in myocardial infarction. N Engl J Med 369(12):1115–1123PubMed Wald DS et al (2013) Randomized trial of preventive angioplasty in myocardial infarction. N Engl J Med 369(12):1115–1123PubMed
131.
Zurück zum Zitat Mehta SR et al (2019) Complete revascularization with multivessel PCI for myocardial infarction. N Engl J Med 381(15):1411–1421PubMed Mehta SR et al (2019) Complete revascularization with multivessel PCI for myocardial infarction. N Engl J Med 381(15):1411–1421PubMed
132.
Zurück zum Zitat Frobert O et al (2013) Thrombus aspiration during ST-segment elevation myocardial infarction. N Engl J Med 369(17):1587–1597PubMed Frobert O et al (2013) Thrombus aspiration during ST-segment elevation myocardial infarction. N Engl J Med 369(17):1587–1597PubMed
133.
Zurück zum Zitat Jolly SS et al (2015) Randomized trial of primary PCI with or without routine manual thrombectomy. N Engl J Med 372(15):1389–1398PubMedPubMedCentral Jolly SS et al (2015) Randomized trial of primary PCI with or without routine manual thrombectomy. N Engl J Med 372(15):1389–1398PubMedPubMedCentral
134.
Zurück zum Zitat Jolly SS et al (2015) Stroke in the TOTAL trial: a randomized trial of routine thrombectomy vs. percutaneous coronary intervention alone in ST elevation myocardial infarction. Eur Heart J 36(35):2364–2372PubMedPubMedCentral Jolly SS et al (2015) Stroke in the TOTAL trial: a randomized trial of routine thrombectomy vs. percutaneous coronary intervention alone in ST elevation myocardial infarction. Eur Heart J 36(35):2364–2372PubMedPubMedCentral
135.
Zurück zum Zitat Holmes DR Jr. et al (1999) Cardiogenic shock in patients with acute ischemic syndromes with and without ST-segment elevation. Circulation 100(20):2067–2073PubMed Holmes DR Jr. et al (1999) Cardiogenic shock in patients with acute ischemic syndromes with and without ST-segment elevation. Circulation 100(20):2067–2073PubMed
136.
Zurück zum Zitat Babaev A et al (2005) Trends in management and outcomes of patients with acute myocardial infarction complicated by cardiogenic shock. JAMA 294(4):448–454PubMed Babaev A et al (2005) Trends in management and outcomes of patients with acute myocardial infarction complicated by cardiogenic shock. JAMA 294(4):448–454PubMed
137.
Zurück zum Zitat Thiele H et al (2017) PCI strategies in patients with acute myocardial infarction and cardiogenic shock. N Engl J Med 377(25):2419–2432PubMed Thiele H et al (2017) PCI strategies in patients with acute myocardial infarction and cardiogenic shock. N Engl J Med 377(25):2419–2432PubMed
138.
Zurück zum Zitat Thiele H et al (2012) Intraaortic balloon support for myocardial infarction with cardiogenic shock. N Engl J Med 367(14):1287–1296PubMed Thiele H et al (2012) Intraaortic balloon support for myocardial infarction with cardiogenic shock. N Engl J Med 367(14):1287–1296PubMed
139.
Zurück zum Zitat Hayes SN et al (2018) Spontaneous coronary artery dissection: current state of the science: a scientific statement from the American Heart Association. Circulation 137(19):e523–e557PubMedPubMedCentral Hayes SN et al (2018) Spontaneous coronary artery dissection: current state of the science: a scientific statement from the American Heart Association. Circulation 137(19):e523–e557PubMedPubMedCentral
140.
Zurück zum Zitat Saw J et al (2017) Spontaneous coronary artery dissection: clinical outcomes and risk of recurrence. J Am Coll Cardiol 70(9):1148–1158PubMed Saw J et al (2017) Spontaneous coronary artery dissection: clinical outcomes and risk of recurrence. J Am Coll Cardiol 70(9):1148–1158PubMed
141.
Zurück zum Zitat Saw J et al (2019) Canadian spontaneous coronary artery dissection cohort study: in-hospital and 30-day outcomes. Eur Heart J 40(15):1188–1197PubMedPubMedCentral Saw J et al (2019) Canadian spontaneous coronary artery dissection cohort study: in-hospital and 30-day outcomes. Eur Heart J 40(15):1188–1197PubMedPubMedCentral
142.
Zurück zum Zitat Nef HM et al (2017) Medikamentenfreisetzende Koronarstents/-scaffolds und medikamentenbeschichtete Ballonkatheter. Kardiologe 12(1):26–52 Nef HM et al (2017) Medikamentenfreisetzende Koronarstents/-scaffolds und medikamentenbeschichtete Ballonkatheter. Kardiologe 12(1):26–52
143.
Zurück zum Zitat Alfonso F et al (2018) 3‑year clinical follow-up of the RIBS IV clinical trial: a prospective randomized study of drug-eluting balloons versus everolimus-eluting stents in patients with in-stent restenosis in coronary arteries previously treated with drug-eluting stents. JACC Cardiovasc Interv 11(10):981–991PubMed Alfonso F et al (2018) 3‑year clinical follow-up of the RIBS IV clinical trial: a prospective randomized study of drug-eluting balloons versus everolimus-eluting stents in patients with in-stent restenosis in coronary arteries previously treated with drug-eluting stents. JACC Cardiovasc Interv 11(10):981–991PubMed
144.
Zurück zum Zitat Hamm CW et al (2020) A multicentre, randomised controlled clinical study of drug-coated balloons for the treatment of coronary in-stent restenosis. EuroIntervention 16(4):e328–e334PubMed Hamm CW et al (2020) A multicentre, randomised controlled clinical study of drug-coated balloons for the treatment of coronary in-stent restenosis. EuroIntervention 16(4):e328–e334PubMed
145.
Zurück zum Zitat Savage MP et al (1995) Effect of thromboxane A2 blockade on clinical outcome and restenosis after successful coronary angioplasty. Multi-Hospital Eastern Atlantic Restenosis Trial (M-HEART II). Circulation 92(11):3194–3200PubMed Savage MP et al (1995) Effect of thromboxane A2 blockade on clinical outcome and restenosis after successful coronary angioplasty. Multi-Hospital Eastern Atlantic Restenosis Trial (M-HEART II). Circulation 92(11):3194–3200PubMed
146.
Zurück zum Zitat Antithrombotic Trialists’ Collaboration (2002) Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 324(7329):71–86 Antithrombotic Trialists’ Collaboration (2002) Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 324(7329):71–86
147.
Zurück zum Zitat Patrono C et al (2004) Expert consensus document on the use of antiplatelet agents. The task force on the use of antiplatelet agents in patients with atherosclerotic cardiovascular disease of the European society of cardiology. Eur Heart J 25(2):166–181PubMed Patrono C et al (2004) Expert consensus document on the use of antiplatelet agents. The task force on the use of antiplatelet agents in patients with atherosclerotic cardiovascular disease of the European society of cardiology. Eur Heart J 25(2):166–181PubMed
148.
Zurück zum Zitat Steg PG et al (2013) Effect of cangrelor on periprocedural outcomes in percutaneous coronary interventions: a pooled analysis of patient-level data. Lancet 382(9909):1981–1992PubMed Steg PG et al (2013) Effect of cangrelor on periprocedural outcomes in percutaneous coronary interventions: a pooled analysis of patient-level data. Lancet 382(9909):1981–1992PubMed
149.
Zurück zum Zitat Harrington RA et al (2009) Platelet inhibition with cangrelor in patients undergoing PCI. N Engl J Med 361(24):2318–2329PubMed Harrington RA et al (2009) Platelet inhibition with cangrelor in patients undergoing PCI. N Engl J Med 361(24):2318–2329PubMed
150.
Zurück zum Zitat Kaluski E et al (2000) Minimal heparinization in coronary angioplasty—how much heparin is really warranted? Am J Cardiol 85(8):953–956PubMed Kaluski E et al (2000) Minimal heparinization in coronary angioplasty—how much heparin is really warranted? Am J Cardiol 85(8):953–956PubMed
151.
Zurück zum Zitat Montalescot G et al (2006) Enoxaparin versus unfractionated heparin in elective percutaneous coronary intervention. N Engl J Med 355(10):1006–1017PubMed Montalescot G et al (2006) Enoxaparin versus unfractionated heparin in elective percutaneous coronary intervention. N Engl J Med 355(10):1006–1017PubMed
152.
Zurück zum Zitat Kastrati A et al (2008) Bivalirudin versus unfractionated heparin during percutaneous coronary intervention. N Engl J Med 359(7):688–696PubMed Kastrati A et al (2008) Bivalirudin versus unfractionated heparin during percutaneous coronary intervention. N Engl J Med 359(7):688–696PubMed
153.
Zurück zum Zitat Wiviott SD et al (2007) Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 357(20):2001–2015PubMed Wiviott SD et al (2007) Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 357(20):2001–2015PubMed
154.
Zurück zum Zitat Wallentin L et al (2009) Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 361(11):1045–1057PubMed Wallentin L et al (2009) Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 361(11):1045–1057PubMed
155.
Zurück zum Zitat Montalescot G et al (2014) Prehospital ticagrelor in ST-segment elevation myocardial infarction. N Engl J Med 371(11):1016–1027PubMed Montalescot G et al (2014) Prehospital ticagrelor in ST-segment elevation myocardial infarction. N Engl J Med 371(11):1016–1027PubMed
156.
Zurück zum Zitat Montalescot G et al (2013) Pretreatment with prasugrel in non-ST-segment elevation acute coronary syndromes. N Engl J Med 369(11):999–1010PubMed Montalescot G et al (2013) Pretreatment with prasugrel in non-ST-segment elevation acute coronary syndromes. N Engl J Med 369(11):999–1010PubMed
157.
Zurück zum Zitat Schupke S et al (2019) Ticagrelor or prasugrel in patients with acute coronary syndromes. N Engl J Med 381(16):1524–1534PubMed Schupke S et al (2019) Ticagrelor or prasugrel in patients with acute coronary syndromes. N Engl J Med 381(16):1524–1534PubMed
158.
Zurück zum Zitat ten Berg JM et al (2010) Effect of early, pre-hospital initiation of high bolus dose tirofiban in patients with ST-segment elevation myocardial infarction on short- and long-term clinical outcome. J Am Coll Cardiol 55(22):2446–2455PubMed ten Berg JM et al (2010) Effect of early, pre-hospital initiation of high bolus dose tirofiban in patients with ST-segment elevation myocardial infarction on short- and long-term clinical outcome. J Am Coll Cardiol 55(22):2446–2455PubMed
159.
Zurück zum Zitat Montalescot G et al (2011) Intravenous enoxaparin or unfractionated heparin in primary percutaneous coronary intervention for ST-elevation myocardial infarction: the international randomised open-label ATOLL trial. Lancet 378(9792):693–703PubMed Montalescot G et al (2011) Intravenous enoxaparin or unfractionated heparin in primary percutaneous coronary intervention for ST-elevation myocardial infarction: the international randomised open-label ATOLL trial. Lancet 378(9792):693–703PubMed
160.
Zurück zum Zitat Silvain J et al (2012) Efficacy and safety of enoxaparin versus unfractionated heparin during percutaneous coronary intervention: systematic review and meta-analysis. BMJ 344:e553PubMedPubMedCentral Silvain J et al (2012) Efficacy and safety of enoxaparin versus unfractionated heparin during percutaneous coronary intervention: systematic review and meta-analysis. BMJ 344:e553PubMedPubMedCentral
161.
Zurück zum Zitat Capodanno D et al (2016) Bivalirudin versus heparin with or without glycoprotein IIb/IIIa inhibitors in patients with STEMI undergoing primary PCI: an updated meta-analysis of 10,350 patients from five randomized clinical trials. Eur Heart J Acute Cardiovasc Care 5(3):253–262PubMed Capodanno D et al (2016) Bivalirudin versus heparin with or without glycoprotein IIb/IIIa inhibitors in patients with STEMI undergoing primary PCI: an updated meta-analysis of 10,350 patients from five randomized clinical trials. Eur Heart J Acute Cardiovasc Care 5(3):253–262PubMed
162.
Zurück zum Zitat Stone GW et al (2006) Bivalirudin for patients with acute coronary syndromes. N Engl J Med 355(21):2203–2216PubMed Stone GW et al (2006) Bivalirudin for patients with acute coronary syndromes. N Engl J Med 355(21):2203–2216PubMed
163.
Zurück zum Zitat Valgimigli M, MATRIX investigators (2014) Design and rationale for the Minimizing Adverse haemorrhagic events by TRansradial access site and systemic Implementation of angioX program. Am Heart J 168(6):838–845PubMed Valgimigli M, MATRIX investigators (2014) Design and rationale for the Minimizing Adverse haemorrhagic events by TRansradial access site and systemic Implementation of angioX program. Am Heart J 168(6):838–845PubMed
164.
Zurück zum Zitat Shahzad A et al (2014) Unfractionated heparin versus bivalirudin in primary percutaneous coronary intervention (HEAT-PPCI): an open-label, single centre, randomised controlled trial. Lancet 384(9957):1849–1858PubMed Shahzad A et al (2014) Unfractionated heparin versus bivalirudin in primary percutaneous coronary intervention (HEAT-PPCI): an open-label, single centre, randomised controlled trial. Lancet 384(9957):1849–1858PubMed
165.
Zurück zum Zitat Leonardi S et al (2016) Bivalirudin or unfractionated heparin in patients with acute coronary syndromes managed invasively with and without ST elevation (MATRIX): randomised controlled trial. BMJ i4935:354 Leonardi S et al (2016) Bivalirudin or unfractionated heparin in patients with acute coronary syndromes managed invasively with and without ST elevation (MATRIX): randomised controlled trial. BMJ i4935:354
166.
Zurück zum Zitat Cannon CP et al (2017) Dual antithrombotic therapy with dabigatran after PCI in atrial fibrillation. N Engl J Med 377(16):1513–1524PubMed Cannon CP et al (2017) Dual antithrombotic therapy with dabigatran after PCI in atrial fibrillation. N Engl J Med 377(16):1513–1524PubMed
167.
Zurück zum Zitat Gibson CM et al (2016) Prevention of bleeding in patients with atrial fibrillation undergoing PCI. N Engl J Med 375(25):2423–2434PubMed Gibson CM et al (2016) Prevention of bleeding in patients with atrial fibrillation undergoing PCI. N Engl J Med 375(25):2423–2434PubMed
168.
Zurück zum Zitat Lopes RD et al (2019) Antithrombotic therapy after acute coronary syndrome or PCI in atrial fibrillation. N Engl J Med 380(16):1509–1524PubMed Lopes RD et al (2019) Antithrombotic therapy after acute coronary syndrome or PCI in atrial fibrillation. N Engl J Med 380(16):1509–1524PubMed
169.
Zurück zum Zitat Dash D (2013) Complications of coronary intervention: abrupt closure, dissection, perforation. Heart Asia 5(1):61–65PubMedPubMedCentral Dash D (2013) Complications of coronary intervention: abrupt closure, dissection, perforation. Heart Asia 5(1):61–65PubMedPubMedCentral
170.
Zurück zum Zitat Giannini F et al (2018) A practical approach to the management of complications during percutaneous coronary intervention. JACC Cardiovasc Interv 11(18):1797–1810PubMed Giannini F et al (2018) A practical approach to the management of complications during percutaneous coronary intervention. JACC Cardiovasc Interv 11(18):1797–1810PubMed
171.
Zurück zum Zitat Albertal M et al (2001) Uncomplicated moderate coronary artery dissections after balloon angioplasty: good outcome without stenting. Heart 86(2):193–198PubMedPubMedCentral Albertal M et al (2001) Uncomplicated moderate coronary artery dissections after balloon angioplasty: good outcome without stenting. Heart 86(2):193–198PubMedPubMedCentral
172.
Zurück zum Zitat Huber MS et al (1991) Use of a morphologic classification to predict clinical outcome after dissection from coronary angioplasty. Am J Cardiol 68(5):467–471PubMed Huber MS et al (1991) Use of a morphologic classification to predict clinical outcome after dissection from coronary angioplasty. Am J Cardiol 68(5):467–471PubMed
173.
Zurück zum Zitat Gibson CM et al (2000) Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugs. Circulation 101(2):125–130PubMed Gibson CM et al (2000) Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugs. Circulation 101(2):125–130PubMed
174.
Zurück zum Zitat Muller O et al (2008) Management of two major complications in the cardiac catheterisation laboratory: the no-reflow phenomenon and coronary perforations. EuroIntervention 4(2):181–183PubMed Muller O et al (2008) Management of two major complications in the cardiac catheterisation laboratory: the no-reflow phenomenon and coronary perforations. EuroIntervention 4(2):181–183PubMed
175.
Zurück zum Zitat Niccoli G et al (2009) Myocardial no-reflow in humans. J Am Coll Cardiol 54(4):281–292PubMed Niccoli G et al (2009) Myocardial no-reflow in humans. J Am Coll Cardiol 54(4):281–292PubMed
176.
Zurück zum Zitat Ross AM et al (2005) A randomized, double-blinded, placebo-controlled multicenter trial of adenosine as an adjunct to reperfusion in the treatment of acute myocardial infarction (AMISTAD-II). J Am Coll Cardiol 45(11):1775–1780PubMed Ross AM et al (2005) A randomized, double-blinded, placebo-controlled multicenter trial of adenosine as an adjunct to reperfusion in the treatment of acute myocardial infarction (AMISTAD-II). J Am Coll Cardiol 45(11):1775–1780PubMed
177.
Zurück zum Zitat Farouque HM et al (2005) Risk factors for the development of retroperitoneal hematoma after percutaneous coronary intervention in the era of glycoprotein IIb/IIIa inhibitors and vascular closure devices. J Am Coll Cardiol 45(3):363–368PubMed Farouque HM et al (2005) Risk factors for the development of retroperitoneal hematoma after percutaneous coronary intervention in the era of glycoprotein IIb/IIIa inhibitors and vascular closure devices. J Am Coll Cardiol 45(3):363–368PubMed
178.
Zurück zum Zitat Maluenda G et al (2012) Retroperitoneal hemorrhage after percutaneous coronary intervention in the current practice era: clinical outcomes and prognostic value of abdominal/pelvic computed tomography. Catheter Cardiovasc Interv 80(1):29–36PubMed Maluenda G et al (2012) Retroperitoneal hemorrhage after percutaneous coronary intervention in the current practice era: clinical outcomes and prognostic value of abdominal/pelvic computed tomography. Catheter Cardiovasc Interv 80(1):29–36PubMed
179.
Zurück zum Zitat Tiroch KA et al (2008) Risk predictors of retroperitoneal hemorrhage following percutaneous coronary intervention. Am J Cardiol 102(11):1473–1476PubMed Tiroch KA et al (2008) Risk predictors of retroperitoneal hemorrhage following percutaneous coronary intervention. Am J Cardiol 102(11):1473–1476PubMed
181.
Zurück zum Zitat Shimony A et al (2011) Coronary artery perforation during percutaneous coronary intervention: a systematic review and meta-analysis. Can J Cardiol 27(6):843–850PubMed Shimony A et al (2011) Coronary artery perforation during percutaneous coronary intervention: a systematic review and meta-analysis. Can J Cardiol 27(6):843–850PubMed
182.
Zurück zum Zitat Dippel EJ et al (2001) Coronary perforation during percutaneous coronary intervention in the era of abciximab platelet glycoprotein IIb/IIIa blockade: an algorithm for percutaneous management. Catheter Cardiovasc Interv 52(3):279–286PubMed Dippel EJ et al (2001) Coronary perforation during percutaneous coronary intervention in the era of abciximab platelet glycoprotein IIb/IIIa blockade: an algorithm for percutaneous management. Catheter Cardiovasc Interv 52(3):279–286PubMed
183.
Zurück zum Zitat Ellis SG et al (1988) Angiographic and clinical predictors of acute closure after native vessel coronary angioplasty. Circulation 77(2):372–379PubMed Ellis SG et al (1988) Angiographic and clinical predictors of acute closure after native vessel coronary angioplasty. Circulation 77(2):372–379PubMed
184.
Zurück zum Zitat Ellis SG et al (1994) Increased coronary perforation in the new device era. Incidence, classification, management, and outcome. Circulation 90(6):2725–2730PubMed Ellis SG et al (1994) Increased coronary perforation in the new device era. Incidence, classification, management, and outcome. Circulation 90(6):2725–2730PubMed
185.
Zurück zum Zitat Brilakis ES et al (2005) Incidence, retrieval methods, and outcomes of stent loss during percutaneous coronary intervention: a large single-center experience. Catheter Cardiovasc Interv 66(3):333–340PubMed Brilakis ES et al (2005) Incidence, retrieval methods, and outcomes of stent loss during percutaneous coronary intervention: a large single-center experience. Catheter Cardiovasc Interv 66(3):333–340PubMed
186.
Zurück zum Zitat Colkesen AY et al (2007) Coronary and systemic stent embolization during percutaneous coronary interventions: a single center experience. Int Heart J 48(2):129–136PubMed Colkesen AY et al (2007) Coronary and systemic stent embolization during percutaneous coronary interventions: a single center experience. Int Heart J 48(2):129–136PubMed
187.
Zurück zum Zitat Alomar ME et al (2013) Stent loss and retrieval during percutaneous coronary interventions: a systematic review and meta-analysis. J Invasive Cardiol 25(12):637–641PubMed Alomar ME et al (2013) Stent loss and retrieval during percutaneous coronary interventions: a systematic review and meta-analysis. J Invasive Cardiol 25(12):637–641PubMed
188.
Zurück zum Zitat Meller J et al (1976) Coronary artery dissection—a complication of cardiac catheterization without sequelae: case report and review of the literature. Cathet Cardiovasc Diagn 2(3):301–308PubMed Meller J et al (1976) Coronary artery dissection—a complication of cardiac catheterization without sequelae: case report and review of the literature. Cathet Cardiovasc Diagn 2(3):301–308PubMed
189.
Zurück zum Zitat Gomez-Moreno S et al (2006) Iatrogenic dissection of the ascending aorta following heart catheterisation: incidence, management and outcome. EuroIntervention 2(2):197–202PubMed Gomez-Moreno S et al (2006) Iatrogenic dissection of the ascending aorta following heart catheterisation: incidence, management and outcome. EuroIntervention 2(2):197–202PubMed
190.
Zurück zum Zitat Dunning DW et al (2000) Iatrogenic coronary artery dissections extending into and involving the aortic root. Catheter Cardiovasc Interv 51(4):387–393PubMed Dunning DW et al (2000) Iatrogenic coronary artery dissections extending into and involving the aortic root. Catheter Cardiovasc Interv 51(4):387–393PubMed
191.
Zurück zum Zitat Röther J, Laufs U, Böhm M, Willems S, Scheller B, Borggrefe M, Darius H, Endres M, Zeymer U, Diener HC, Grond M, Hacke W, Forsting M, Schumacher M, Hennerici M (2009) Konsensuspapier „Peri- und postinterventioneller Schlaganfall bei Herzkatheterprozeduren“. Kardiologe (3):375–387 Röther J, Laufs U, Böhm M, Willems S, Scheller B, Borggrefe M, Darius H, Endres M, Zeymer U, Diener HC, Grond M, Hacke W, Forsting M, Schumacher M, Hennerici M (2009) Konsensuspapier „Peri- und postinterventioneller Schlaganfall bei Herzkatheterprozeduren“. Kardiologe (3):375–387
192.
Zurück zum Zitat Aggarwal A et al (2009) Incidence and predictors of stroke associated with percutaneous coronary intervention. Am J Cardiol 104(3):349–353PubMed Aggarwal A et al (2009) Incidence and predictors of stroke associated with percutaneous coronary intervention. Am J Cardiol 104(3):349–353PubMed
193.
Zurück zum Zitat Dukkipati S et al (2004) Characteristics of cerebrovascular accidents after percutaneous coronary interventions. J Am Coll Cardiol 43(7):1161–1167PubMed Dukkipati S et al (2004) Characteristics of cerebrovascular accidents after percutaneous coronary interventions. J Am Coll Cardiol 43(7):1161–1167PubMed
194.
Zurück zum Zitat München O (2010) Urt. v. 18.11.2010 – 1 U 5334/09, GesR 2011, 235, 236 = juris Nr. 35, 37, 44, 45: Bei Aufklärung durch Assistenzarzt München O (2010) Urt. v. 18.11.2010 – 1 U 5334/09, GesR 2011, 235, 236 = juris Nr. 35, 37, 44, 45: Bei Aufklärung durch Assistenzarzt
195.
Zurück zum Zitat Frahm, Nixdorf, Walter (2013) 5. Aufl., Rz. 215 zu § 630 e II 1 Nr. 1 BGB Frahm, Nixdorf, Walter (2013) 5. Aufl., Rz. 215 zu § 630 e II 1 Nr. 1 BGB
196.
Zurück zum Zitat Martis, Winkhart (2014) 4. Aufl., Rz. A 1757 ff. und Rz. P 44, P 48 Martis, Winkhart (2014) 4. Aufl., Rz. A 1757 ff. und Rz. P 44, P 48
197.
Zurück zum Zitat Montalescot G et al (2013) 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J 34(38):2949–3003PubMed Montalescot G et al (2013) 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J 34(38):2949–3003PubMed
198.
Zurück zum Zitat Campeau L (1976) Letter: grading of angina pectoris. Circulation 54(3):522–523PubMed Campeau L (1976) Letter: grading of angina pectoris. Circulation 54(3):522–523PubMed
200.
Zurück zum Zitat Sianos G et al (2005) The SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease. EuroIntervention 1(2):219–227PubMed Sianos G et al (2005) The SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease. EuroIntervention 1(2):219–227PubMed
201.
Zurück zum Zitat Medina A, Suarez de Lezo J, Pan M (2006) A new classification of coronary bifurcation lesions. Rev Esp Cardiol 59(2):183PubMed Medina A, Suarez de Lezo J, Pan M (2006) A new classification of coronary bifurcation lesions. Rev Esp Cardiol 59(2):183PubMed
202.
Zurück zum Zitat Mehran R et al (1999) Angiographic patterns of in-stent restenosis: classification and implications for long-term outcome. Circulation 100(18):1872–1878PubMed Mehran R et al (1999) Angiographic patterns of in-stent restenosis: classification and implications for long-term outcome. Circulation 100(18):1872–1878PubMed
203.
Zurück zum Zitat Rentrop KP et al (1985) Changes in collateral channel filling immediately after controlled coronary artery occlusion by an angioplasty balloon in human subjects. J Am Coll Cardiol 5(3):587–592PubMed Rentrop KP et al (1985) Changes in collateral channel filling immediately after controlled coronary artery occlusion by an angioplasty balloon in human subjects. J Am Coll Cardiol 5(3):587–592PubMed
Metadaten
Titel
Manual der Arbeitsgruppe Interventionelle Kardiologie (AGIK) der Deutschen Gesellschaft für Kardiologie – Herz- und Kreislaufforschung e.V. (DGK)
Teil 2: „Durchführung der perkutanen Koronarintervention“
verfasst von
Prof. Dr. med. Holger M. Nef
Stephan Achenbach
Ralf Birkemeyer
Alexander Bufe
Oliver Dörr
Albrecht Elsässer
Luise Gaede
Tommaso Gori
Hans M. Hoffmeister
Felix J. Hofmann
Hugo A. Katus
Christoph Liebetrau
Steffen Massberg
Matthias Pauschinger
Thomas Schmitz
Tim Süselbeck
Wolfram Voelker
Jens Wiebe
Ralf Zahn
Christian Hamm
Andreas M. Zeiher
Helge Möllmann
Publikationsdatum
21.09.2021
Verlag
Springer Medizin
Erschienen in
Die Kardiologie / Ausgabe 6/2021
Print ISSN: 2731-7129
Elektronische ISSN: 2731-7137
DOI
https://doi.org/10.1007/s12181-021-00504-6

Weitere Artikel der Ausgabe 6/2021

Die Kardiologie 6/2021 Zur Ausgabe

Wie lautet Ihre Diagnose?

Die Dyspnoe beginnt im Sitzen

Passend zum Thema

ANZEIGE

SGLT-2-Inhibitoren für alle Patient:innen mit chronischer Herzinsuffizienz empfohlen

Das ESC-Leitlinien-Update 2023 bedeutet einen Paradigmenwechsel in der Behandlung der Herzinsuffizienz (HF), denn nun werden SGLT-2i sowohl für HFrEF, als auch für HFmrEF und HFpEF empfohlen. Somit können jetzt alle Patient:innen mit HF von SGLT-2i als zentralem Bestandteil der Therapie profitieren.

ANZEIGE

Dapagliflozin als neue Therapieoption zur Behandlung einer Herzinsuffizienz unabhängig von der Ejektionsfraktion

Dapagliflozin ist nun zur Behandlung aller Patient:innen mit chronischer symptomatischer Herzinsuffizienz zugelassen und bietet somit auch neue Hoffnung für die Therapie von jenen mit HFpEF. In der DELIVER-Studie zeigte der SGLT-2-Inhibitor eine signifikante Reduktion von Herzinsuffizienz-Hospitalisierungen und CV-Todesfällen.

ANZEIGE

ACS-Erstlinientherapie: Konsensbeschluss rät zur DAPT mit Ticagrelor

Ein Konsortium führender Fachgesellschaften erarbeitete jüngst auf Basis umfangreicher Metaanalysen einen Konsens für die Therapie koronarer Herzkrankheiten. Was dabei auffiel: Die duale Plättchenhemmung (DAPT) mit Ticagrelor ist die bevorzugte Therapieoption für das akute Koronarsyndrom (ACS).